Company Valuation: Hester Biosciences Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2019 2020 2021 2022 2023 2024
Capitalization 1 13,146 7,869 16,306 23,099 12,934 11,818
Change - -40.14% 107.21% 41.66% -44% -8.63%
Enterprise Value (EV) 1 13,627 8,900 17,190 25,128 15,528 14,109
Change - -34.69% 93.14% 46.18% -38.21% -9.14%
P/E ratio 31.6x 27x 47.4x 58.7x 48.6x 62.6x
PBR 7.41x 3.91x 7.14x 8.88x 4.62x 4.05x
PEG - -0.9x 2.6x 4.1x -1.5x -2.2x
Capitalization / Revenue 7.14x 4.19x 7.49x 9.37x 4.65x 3.8x
EV / Revenue 7.4x 4.74x 7.9x 10.2x 5.58x 4.53x
EV / EBITDA 18.4x 14.7x 23.9x 35.2x 24.9x 23.5x
EV / EBIT 21.8x 18.8x 29.1x 45.7x 36.9x 32.7x
EV / FCF 340x -18.6x 1,007x -32.9x -30.6x 128x
FCF Yield 0.29% -5.38% 0.1% -3.04% -3.27% 0.78%
Dividend per Share 2 11 6.6 10 10 8 6
Rate of return 0.71% 0.71% 0.52% 0.37% 0.53% 0.43%
EPS 2 48.86 34.29 40.47 46.22 31.3 22.2
Distribution rate 22.5% 19.2% 24.7% 21.6% 25.6% 27%
Net sales 1 1,842 1,878 2,177 2,466 2,782 3,112
EBITDA 1 742.6 604 720.3 712.9 624.2 600
EBIT 1 625.6 472.3 591.2 550.4 420.3 431.3
Net income 1 415.7 291.7 344.3 393.2 266.3 188.9
Net Debt 1 481.8 1,031 884.3 2,030 2,593 2,291
Reference price 2 1,545.30 925.05 1,916.75 2,715.30 1,520.45 1,389.25
Nbr of stocks (in thousands) 8,507 8,507 8,507 8,507 8,507 8,507
Announcement Date 05/07/19 04/08/20 23/07/21 29/07/22 23/08/23 26/07/24
1INR in Million2INR
Estimates

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 18Cr
25.95x7.75x17.62x1.29% 6.9TCr
-1064.29x2.41x12.69x-.--% 740Cr
18.63x1.65x7.89x1.9% 366.64Cr
18.1x1.99x10.01x0.47% 333.97Cr
46.66x4.98x17.74x-.--% 230.43Cr
28.26x1.44x9.67x1.56% 124.84Cr
20.37x2.64x11.41x2.27% 124.69Cr
15.42x1.24x6.29x1.23% 107.6Cr
30.12x - - 1.46% 107.26Cr
Average -95.64x 3.01x 11.67x 1.13% 905.23Cr
Weighted average by Cap. -63.53x 6.53x 16.20x 1.16%
See all sector valuations

Year-on-year evolution of the PER

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. HESTERBIO Stock
  4. Valuation Hester Biosciences Limited